D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$862M |
| 2 |
Baidu
BIDU
|
+$752M |
| 3 |
Tencent Music
TME
|
+$426M |
| 4 |
Coca-Cola
KO
|
+$424M |
| 5 |
NVIDIA
NVDA
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$981M |
| 2 |
Wells Fargo
WFC
|
+$673M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$574M |
| 4 |
Moderna
MRNA
|
+$442M |
| 5 |
DuPont de Nemours
DD
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.93% |
| 2 | Consumer Discretionary | 10.48% |
| 3 | Healthcare | 8.56% |
| 4 | Communication Services | 8.41% |
| 5 | Financials | 6.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NXDR
2026
Nextdoor Holdings
NXDR
$877M
| $3.33M | ﹤0.01% |
+329,617
| New | +$3.3M |
|
|
APHA
2027
DELISTED
Aphria Inc. Common Shares
APHA
| $3.32M | ﹤0.01% |
180,903
+108,337
| +149% | +$1.76M |
|
2028
Allstate
ALL
$70.1B
| $3.32M | ﹤0.01% |
28,906
-255,137
| -90% | -$28.1M |
|
|
TMX
2029
DELISTED
Terminix Global Holdings, Inc.
TMX
| $3.32M | ﹤0.01% |
69,603
-524,855
| -88% | -$25.9M |
|
2030
Allegiant Air
ALGT
$2.73B
| $3.31M | ﹤0.01% |
13,561
-64,994
| -83% | -$14.4M |
|
2031
Bio-Rad Laboratories Class A
BIO
$8.86B
| $3.31M | ﹤0.01% |
5,792
-2,122
| -27% | -$1.26M |
|
2032
PUT
Cardinal Health
CAH
$54.5B
| $3.31M | ﹤0.01% |
54,400
-39,700
| -42% | -$2.19M |
|
2033
PUT
KLA
KLAC
$249B
| $3.3M | ﹤0.01% |
100,000
-22,000
| -18% | -$663K |
|
2034
Arcturus Therapeutics
ARCT
$163M
| $3.3M | ﹤0.01% |
+79,938
| New | +$4.77M |
|
2035
Kemper
KMPR
$1.82B
| $3.3M | ﹤0.01% |
+41,369
| New | +$3.19M |
|
2036
PUT
United Rentals
URI
$67.9B
| $3.29M | ﹤0.01% |
10,000
-46,100
| -82% | -$13.1M |
|
2037
Par Pacific Holdings
PARR
$3.97B
| $3.29M | ﹤0.01% |
232,984
-48,567
| -17% | -$755K |
|
|
SGI
2038
PUT
Somnigroup International
SGI
$15.2B
| $3.29M | ﹤0.01% |
90,000
| – | – |
|
|
IVC
2039
DELISTED
Invacare Corporation
IVC
| $3.28M | ﹤0.01% |
409,314
-6,581
| -2% | -$61.3K |
|
|
THCA
2040
DELISTED
Tuscan Holdings Corp. II Common Stock
THCA
| $3.28M | ﹤0.01% |
325,000
| – | – |
|
2041
Standard Motor Products
SMP
$897M
| $3.28M | ﹤0.01% |
78,768
+37,795
| +92% | +$1.61M |
|
2042
CALL
Generac Holdings
GNRC
$11.5B
| $3.27M | ﹤0.01% |
+10,000
| New | +$2.95M |
|
|
SRNE
2043
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $3.27M | ﹤0.01% |
395,305
+62,967
| +19% | +$665K |
|
|
EBIX
2044
DELISTED
Ebix Inc
EBIX
| $3.27M | ﹤0.01% |
102,027
-120,386
| -54% | -$4.64M |
|
2045
Daktronics
DAKT
$953M
| $3.26M | ﹤0.01% |
519,521
+26,035
| +5% | +$147K |
|
2046
Gibraltar Industries
ROCK
$1.39B
| $3.26M | ﹤0.01% |
35,591
-87,496
| -71% | -$8.03M |
|
|
TGH
2047
DELISTED
Textainer Group Holdings limited
TGH
| $3.26M | ﹤0.01% |
113,695
+83,357
| +275% | +$1.93M |
|
2048
Columbia Banking Systems
COLB
$8.84B
| $3.25M | ﹤0.01% |
75,504
+52,864
| +233% | +$2.3M |
|
2049
Radware
RDWR
$1.19B
| $3.25M | ﹤0.01% |
124,647
-79,697
| -39% | -$2.18M |
|
|
BAND
2050
Bandwidth Inc
BAND
$1.67B
| $3.24M | ﹤0.01% |
25,597
-81,815
| -76% | -$12.7M |
|
Similar funds
D.E. Shaw & Co's Q1 2021 Portfolio in Review
As of Q1 2021, D.E. Shaw & Co held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
D.E. Shaw & Co withdrew a net $18.3B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Baidu worth $627M.
- D.E. Shaw & Co's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
- D.E. Shaw & Co added most to Tesla in Q1 2021, an estimated $862M increase.
- D.E. Shaw & Co's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
- D.E. Shaw & Co fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
- D.E. Shaw & Co's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
- D.E. Shaw & Co opened 825 new positions and closed 730 in Q1 2021.
- D.E. Shaw & Co's portfolio value fell 7.4% quarter-over-quarter to $104B.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.